137 related articles for article (PubMed ID: 22650303)
21. Bioartificial liver systems: current status and future perspective.
Park JK; Lee DH
J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
[TBL] [Abstract][Full Text] [Related]
22. Artificial hepatic support systems.
Demetriou AA; Watanabe F; Rozga J
Prog Liver Dis; 1995; 13():331-48. PubMed ID: 9224509
[TBL] [Abstract][Full Text] [Related]
23. The HepaRG cell line is suitable for bioartificial liver application.
Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
[TBL] [Abstract][Full Text] [Related]
24. Recent developments on human cell lines for the bioartificial liver.
Hoekstra R; Chamuleau RA
Int J Artif Organs; 2002 Mar; 25(3):182-91. PubMed ID: 11999190
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.
Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R
J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687
[TBL] [Abstract][Full Text] [Related]
26. A theoretical method to improve and optimize the design of bioartificial livers.
Davidson AJ; Ellis MJ; Chaudhuri JB
Biotechnol Bioeng; 2010 Aug; 106(6):980-8. PubMed ID: 20506230
[TBL] [Abstract][Full Text] [Related]
27. Use of bioartificial and artificial liver support devices.
Hughes RD; Williams R
Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956
[TBL] [Abstract][Full Text] [Related]
28. The optimal hepatocyte density for a hollow-fiber bioartificial liver.
Xu Q; Sun X; Qiu Y; Zhang H; Ding Y
Ann Clin Lab Sci; 2004; 34(1):87-93. PubMed ID: 15038673
[TBL] [Abstract][Full Text] [Related]
29. Bioartificial liver: its pros and cons.
Chamuleau RA; Poyck PP; van de Kerkhove MP
Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
[TBL] [Abstract][Full Text] [Related]
30. A promising hepatocyte-like cell line, CCL-13, exhibits good liver function both in vitro and in an acute liver failure model.
Yang T; Li C; Zhang L; Li M; Zhou P
Transplant Proc; 2013 Mar; 45(2):688-94. PubMed ID: 23498808
[TBL] [Abstract][Full Text] [Related]
31. Hepatic assist devices: will they ever be successful?
Sussman NL; McGuire BM; Kelly JH
Curr Gastroenterol Rep; 2009 Feb; 11(1):64-8. PubMed ID: 19166661
[TBL] [Abstract][Full Text] [Related]
32. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.
Tsiaoussis J; Newsome PN; Nelson LJ; Hayes PC; Plevris JN
Liver Transpl; 2001 Jan; 7(1):2-10. PubMed ID: 11150414
[TBL] [Abstract][Full Text] [Related]
33. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
Kobayashi N
J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
[TBL] [Abstract][Full Text] [Related]
34. Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver.
Nedredal GI; Elvevold K; Ytrebø LM; Fuskevåg OM; Pettersen I; Bertheussen K; Langbakk B; Smedsrød B; Revhaug A
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G75-83. PubMed ID: 17363468
[TBL] [Abstract][Full Text] [Related]
35. Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver.
Shi XL; Zhang Y; Han B; Gu JY; Chu XH; Xiao JQ; Ren HZ; Tan JJ; Ding YT
Artif Organs; 2011 Mar; 35(3):E40-6. PubMed ID: 21371057
[TBL] [Abstract][Full Text] [Related]
36. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
Di Nicuolo G; van de Kerkhove MP; Hoekstra R; Beld MG; Amoroso P; Battisti S; Starace M; di Florio E; Scuderi V; Scala S; Bracco A; Mancini A; Chamuleau RA; Calise F
Xenotransplantation; 2005 Jul; 12(4):286-92. PubMed ID: 15943777
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
[TBL] [Abstract][Full Text] [Related]
38. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
Andersson TB; Kanebratt KP; Kenna JG
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
[TBL] [Abstract][Full Text] [Related]
39. Cryopreserved human hepatocytes from cell bank: in vitro function and clinical application.
Baccarani U; Sanna A; Cariani A; Sainz M; Adani GL; Lorenzin D; Montanaro D; Scalamogna M; Piccolo G; Risaliti A; Bresadola F; Donini A
Transplant Proc; 2005; 37(1):256-9. PubMed ID: 15808612
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a hybrid artificial liver module based on a spheroid culture system of embryonic stem cell-derived hepatic cells.
Mizumoto H; Hayashi S; Matsumoto K; Ikeda K; Kusumi T; Inamori M; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
Cell Transplant; 2012; 21(2-3):421-8. PubMed ID: 22793049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
